Moody National Bank Trust Division Intercept Pharmaceuticals, Inc. Transaction History

Moody National Bank Trust Division

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2019 Apr 11, 2019	SELL	$91.83 - $120.68 $4,407 - $5,792	-48 Closed	0 $0
Q4 2018 Jan 07, 2019	BUY	$85.79 - $126.46 $4,117 - $6,070	48 New	48 $5,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Moody National Bank Trust Division, based on Form 13F filings with the SEC.

Stay updated on Moody National Bank Trust Division with notifications on news.